These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 7687471

  • 1. Granulocyte colony-stimulating factor (rh G-CSF) as an adjunct to interferon alpha therapy of neutropenic patients with hairy cell leukemia.
    Lorber C, Willfort A, Ohler L, Jäger U, Schwarzinger I, Lechner K, Geissler K.
    Ann Hematol; 1993 Jul; 67(1):13-6. PubMed ID: 7687471
    [Abstract] [Full Text] [Related]

  • 2. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.
    Glaspy JA, Souza L, Scates S, Narachi M, Blatt L, Ambersley J, Golde DW.
    J Immunother (1991); 1992 Apr; 11(3):198-208. PubMed ID: 1381218
    [Abstract] [Full Text] [Related]

  • 3. Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult acute lymphoblastic leukemia (ALL).
    Scherrer R, Geissler K, Kyrle PA, Gisslinger H, Jäger U, Bettelheim P, Laczika K, Locker G, Scholten C, Sillaber C.
    Ann Hematol; 1993 Jun; 66(6):283-9. PubMed ID: 7686404
    [Abstract] [Full Text] [Related]

  • 4. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor.
    Glaspy JA, Baldwin GC, Robertson PA, Souza L, Vincent M, Ambersley J, Golde DW.
    Ann Intern Med; 1988 Nov 15; 109(10):789-95. PubMed ID: 2461131
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Defective synthesis of granulocyte-colony stimulating factor in pegylated interferon-alpha treated chronic hepatitis C patients with declining leukocyte counts.
    Durante-Mangoni E, Iardino P, Utili R, Adinolfi LE, Ruggiero G.
    Antivir Ther; 2006 Nov 15; 11(5):637-40. PubMed ID: 16964833
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.
    Nohynek GJ, Plard JP, Wells MY, Zerial A, Roquet F.
    Cancer Chemother Pharmacol; 1997 Nov 15; 39(3):259-66. PubMed ID: 8996530
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of recombinant canine granulocyte colony-stimulating factor as an inducer of granulopoiesis. A pilot study.
    Obradovich JE, Ogilvie GK, Powers BE, Boone T.
    J Vet Intern Med; 1991 Nov 15; 5(2):75-9. PubMed ID: 2061868
    [Abstract] [Full Text] [Related]

  • 11. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
    Fulton R, Gasper PW, Ogilvie GK, Boone TC, Dornsife RE.
    Exp Hematol; 1991 Sep 15; 19(8):759-67. PubMed ID: 1714401
    [Abstract] [Full Text] [Related]

  • 12. Recombinant human granulocyte colony-stimulating factor promotes wound healing in a patient with congenital neutropenia.
    Besner GE, Glick PL, Karp MP, Wang WC, Lobe TE, White CR, Cooney DR.
    J Pediatr Surg; 1992 Mar 15; 27(3):288-90; discussion 291. PubMed ID: 1380074
    [Abstract] [Full Text] [Related]

  • 13. Recombinant human granulocyte colony stimulating factor in cyclic neutropenia: use of a new 3-day-a-week regimen.
    Jayabose S, Tugal O, Sandoval C, Li K.
    Am J Pediatr Hematol Oncol; 1994 Nov 15; 16(4):338-40. PubMed ID: 7526722
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.
    Lauria F, Bocchia M, Marotta G, Raspadori D, Zinzani PL, Rondelli D.
    Haematologica; 1999 Jan 15; 84(1):22-5. PubMed ID: 10091389
    [Abstract] [Full Text] [Related]

  • 17. [The effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on childhood neutropenias].
    Ueda K, Hanawa Y, Takaku F, Asano S, Tsukimoto I, Tsuchida M, Sato T, Ohira M, Hoshi Y, Nishihira K.
    Rinsho Ketsueki; 1991 Mar 15; 32(3):212-20. PubMed ID: 1710294
    [Abstract] [Full Text] [Related]

  • 18. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M, Karasawa M, Naruse T, Fukuda M, Hirashima K, Oh H, Ninomiya H, Abe T, Saito K, Shishido H, Moriyama Y, Shibata A, Motoyoshi K, Nagata N, Miura Y.
    Int J Hematol; 1999 Feb 15; 69(2):81-8. PubMed ID: 10071455
    [Abstract] [Full Text] [Related]

  • 19. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF, Chan HO.
    Pharmacotherapy; 2005 Mar 15; 25(3):372-8. PubMed ID: 15843284
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.